These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 12908169

  • 1. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
    Tesar V.
    Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
    [Abstract] [Full Text] [Related]

  • 2. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 3. [Renoprotective effects of antihypertensives].
    Monhart V.
    Vnitr Lek; 2004 Jul; 50(7):531-6. PubMed ID: 15323261
    [Abstract] [Full Text] [Related]

  • 4. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
    Hirsch S.
    Compr Ther; 2009 Jul; 35(2):91-5. PubMed ID: 19618757
    [Abstract] [Full Text] [Related]

  • 5. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U, Mayer G.
    Wien Klin Wochenschr; 1995 Jul; 107(1):10-4. PubMed ID: 7871784
    [Abstract] [Full Text] [Related]

  • 6. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
    Lenz T, August P.
    Wien Klin Wochenschr; 1990 May 25; 102(11):315-9. PubMed ID: 2195780
    [Abstract] [Full Text] [Related]

  • 7. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function.
    Saelen MG, Prøsch LK, Gudmundsdottir H, Dyrbekk D, Helge Hunderi O, Arnesen E, Paulsen D, Skjønsberg H, Os I.
    Blood Press; 2005 May 25; 14(3):170-6. PubMed ID: 16036497
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S, Aurell M.
    J Am Soc Nephrol; 1990 Nov 25; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [Abstract] [Full Text] [Related]

  • 9. Losartan in diabetic nephropathy.
    Perico N, Ruggenenti P, Remuzzi G.
    Expert Rev Cardiovasc Ther; 2004 Jul 25; 2(4):473-83. PubMed ID: 15225108
    [Abstract] [Full Text] [Related]

  • 10. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May 25; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 11. Toward better renoprotection: lessons from angiotensin receptor blockers.
    Miyata T, Takizawa S.
    Hemodial Int; 2007 Apr 25; 11(2):164-8. PubMed ID: 17403166
    [Abstract] [Full Text] [Related]

  • 12. [The ACE inhibitor spirapril in chronic renal failure, hypertension and diabetic nephropathy].
    Elliot HL.
    Ter Arkh; 2000 Apr 25; 72(10):78-82. PubMed ID: 11220886
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F, Rangoonwala B.
    Int J Clin Pract; 2003 Nov 25; 57(9):801-22. PubMed ID: 14686572
    [Abstract] [Full Text] [Related]

  • 14. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Nov 25; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 15. Dual blockade of the renin-angiotensin system in chronic renal disease: to do or not to do.
    Nakao N, Seno H, Kasuga H, Toriyama T, Kawahara H.
    Clin Exp Nephrol; 2004 Sep 25; 8(3):183-7. PubMed ID: 15480894
    [Abstract] [Full Text] [Related]

  • 16. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB, Coffman TM.
    Semin Nephrol; 2007 Mar 25; 27(2):144-52. PubMed ID: 17418683
    [Abstract] [Full Text] [Related]

  • 17. Progression of chronic kidney disease: can it be prevented or arrested?
    Jaber BL, Madias NE.
    Am J Med; 2005 Dec 25; 118(12):1323-30. PubMed ID: 16378772
    [Abstract] [Full Text] [Related]

  • 18. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P.
    Nephrology (Carlton); 2007 Feb 25; 12(1):81-9. PubMed ID: 17295666
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
    Tong PC, Ko GT, Chan WB, Ma RC, So WY, Lo MK, Lee KF, Ozaki R, Chow CC, Cockram CS, Chan JC.
    Diabetes Obes Metab; 2006 May 25; 8(3):342-7. PubMed ID: 16634995
    [Abstract] [Full Text] [Related]

  • 20. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK, Epstein M.
    Clin J Am Soc Nephrol; 2006 Sep 25; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.